Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system

By sjmartinez • June 30, 2024

Mohr K, Keeling B, Kaier K, Neusius T, Rosovsky RP, Moriarty JM, Rosenfield K, Abele C, Farmakis IT, Keller K, Barco S, Channick RN, Giri JS, Lookstein RA, Todoran TM, Christodoulou KC, Hobohm L, Lanno M, Reed J, Binder H, Konstantinides SV, Valerio L, Secemsky EA. Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system. Eur Heart J Acute Cardiovasc Care. 2024 Jun 30;13(6):501-505. doi: 10.1093/ehjacc/zuae019. PMID: 38349225; PMCID: PMC11214584.

Tags: Cardiology/Epi, Catheter-directed treatment, Cost of illness, Economic impact, Hospitalization costs, Publications, pulmonary embolism, Pulmonary, Critical Care & Sleep Medicine

Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry

Aksu T, Piotrowski R, Tung R, De Potter T, Markman TM, du Fay de Lavallaz J, Rekvava R, Alyesh D, Joza JE, Badertscher P, Do[...]

Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans

Hashemi L, Marijic Buljubasic A, Budoff MJ, Copeland LA, Jackson NJ, Jasuja GK, Gornbein J, Reue K. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender[...]

Serine protease inhibitor, SerpinA3n, regulates cardiac remodelling after myocardial infarction

Sun Q, Chen W, Wu R, Tao B, Wang P, Sun B, Alvarez JF, Ma F, Galindo DC, Maroney SP, Saviola AJ, Hansen KC, Li[...]